Home/Filings/4/0001326110-23-000107
4//SEC Filing

LAUER REGAN J 4

Accession 0001326110-23-000107

CIK 0001326110other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 9:00 PM ET

Size

6.0 KB

Accession

0001326110-23-000107

Insider Transaction Report

Form 4
Period: 2023-08-25
LAUER REGAN J
Chief Accounting Officer
Transactions
  • Award

    Restricted Stock Units

    2023-08-25+65,74465,744 total
    Common Stock (65,744 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
  • [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, fifty percent (50%) of the RSUs subject to the award shall vest on September 1, 2023 and the remaining fifty percent (50%) of the RSUs subject to the award shall vest on January 31, 2024.

Issuer

ImmunityBio, Inc.

CIK 0001326110

Entity typeother

Related Parties

1
  • filerCIK 0001200637

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 9:00 PM ET
Size
6.0 KB